Michio Tsukamura, Hisao Shimoide, Nobuhiko Kita, Keishi Kawakami, Tadao Ito, Naoto Nakajima, Hiroko Kondo, Yoshitaka Yamamoto, Noboru Matsuda, Masatoshi Tamura, Kazuo ...
January 27, 2014 – Osaka, Japan and Rockville, MD, USA - Japan's National Institute of Biomedical Innovation("NIBIO"), Aerasand Create Vaccine Company, Ltd("CREATE") announce today that they signed a ...
Despite a decline after World War II, the rate of tuberculosis in Japan remains high. Infection is heavily concentrated in the >=60-year age group, and 82% of patients are >=40 years of age. The ...
TOKYO and NEW YORK, Nov. 7, 2013 /PRNewswire-USNewswire/ -- The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment ...
Even as high-income countries roll out Covid-19 vaccine boosters and stockpile millions of vaccine doses, many low- and middle-income countries are struggling to obtain vaccines. Whereas 76% of people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback